HOME
ABOUT US
DAIICHI SANKYO
NEWS
CAREER
OPPORTUNITIES
CONTRACT MANUFACTURING
SERVICES
CONTACT US
American Regent
Regency Therapeutics
Animal Health
Osteohealth

News

  U.S. Reining Team to wear Adequan® Brand at 2014 World Equestrian
6/20/2014
  Shirley, NY (May 23, 2014) - Luitpold Animal Health, a division of Luitpold Pharmaceuticals, Inc., manufacturers of Adequan® i.m. (polysulfated glycosaminoglycan), Adequan® I.A. (polysulfated glycosaminoglycan), and Adequan® Canine (polysulfated glycosaminoglycan) provides the following supply update
5/23/2014
  American Regent’s Injectafer® (Ferric Carboxymaltose Injection) Assigned Q Code by Centers for Medicare and Medicaid Services
5/7/2014
  Luitpold Animal Health - Adequan Press Release
4/1/2014
  Sunshine Act Statement
10/22/2013
  Injectafer® (ferric carboxymaltose injection) receives US FDA approval for the treatment of Iron Deficiency Anemia
7/25/2013
  American Regent announces new PDUFA action date for Injectafer® (ferric carboxymaltose injection) NDA for the treatment of iron deficiency anemia
4/8/2013
  Epinephrine Injection, USP Important Drug Administration Information
2/5/2013
  Methylergonovine Heathcare Professional Letter
12/20/2012
  American Regent Anounces an FDA Pediatric Indication Exclusivity for Venofer (Iron Sucrose Injection, USP)
10/19/2012
  American Regent announces a new FDA-Approved Pediatric Indication for Venofer® (Iron Sucrose Injection, USP)
9/26/2012
  Luitpold Pharmaceuticals, Inc. Receives Complete Response Letter for Injectafer® from the U.S. Food and Drug Administration
7/26/2012
  National Registry Study Evaluating Utility of SPRIX® (ketorolac tromethamine) Nasal Spray, a Non-Narcotic Alternative for Pain Management after Emergency Department Care, Begins
6/25/2012
  American Regent Initiates Nationwide Voluntary Recall of Cyanocobalamin Injection, USP, 1000 mcg/mL, 1 mL Vial, Lot #s 1662, 1679, 1683 Due to Cracks in the Vials
4/2/2012
  FDA Assigns PDUFA Date for Injectafer® (ferric carboxymaltose injection) NDA
12/15/2011
123